Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | APAF1 | O14727 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.36 |
| ▸ | GALK1 | P51570 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19998676 | 0.96 | MAPT (0.36) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL15038395 | 0.94 | ALDH1A1 (0.39) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL1963812 | 0.94 | ALDH1A1 (0.39) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL29401483 | 0.94 | ALDH1A1 (0.39) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL19998671 | 0.94 | ALDH1A1 (0.39) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL19998699 | 0.93 | MAPT (0.34) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL23108829 | 0.92 | ALDH1A1 (0.40) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL22259170 | 0.92 | ALDH1A1 (0.38) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL7787028 | 0.92 | ALDH1A1 (0.40) | MAPTL3MBTL1MEN1NPC1LMNA | |
| SCHEMBL21168417 | 0.92 | ALDH1A1 (0.38) | MAPTL3MBTL1MEN1NPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2620425-A1 | Arylamine compound and organic electroluminescence device | Hodogaya Chemical Co., Ltd. (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-8227096-B2 | Arylamine compound and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-07-24 | — | — | US | disclosed |
| US-20110133171-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-7867632-B2 | Arylamine compound and organic electroluminescence device | HODOGAYA CHEMICAL CO., LTD (JP) | 2011-01-11 | — | — | US | disclosed |
| US-20090278442-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | HODOGAYA CHEMICAL CO., LTD (JP) | 2009-11-12 | — | — | US | disclosed |
| EP-1942098-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | Hodogaya Chemical Co., Ltd. (JP) | 2008-07-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110133171-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | NAT1, TRDMT1, BMI1 | MAPT 3960/4885L3MBTL1 743/4885MEN1 2414/4885 |
| US-20090278442-A1 | ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE | NAT1, MLLT1, TRDMT1 | MAPT 3116/4885L3MBTL1 504/4885MEN1 2382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.